Orthobiologics Market

Orthobiologics Market (Product: Allografts, Xenografts, Synthetic Bone Grafts, Demineralized Bone Matrix, Viscosupplementation, Platelet-rich Plasma, Bone Marrow Aspirate Concentrate, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Global Orthobiologics Market Outlook 2031

  • The global industry was valued at US$ 8.4 Bn in 2022
  • It is projected to grow at a CAGR of 5.5% from 2023 to 2031 and reach more than US$ 13.8 Bn by the end of 2031

Analysts’ Viewpoint

Increase in incidence of bone diseases is expected to drive the global orthobiologics market during the forecast period. Introduction of new products with advanced technology by various companies contributes to market expansion. Rise in healthcare spending and surge in awareness about the benefits of early detection and treatment of bone diseases are likely to propel industry development. Furthermore, increase in adoption of bone grafts, such as allografts and xenografts, and concentration of platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC), and others in emerging economies are fueling market progress.

Merger & acquisition and increase in investment in orthobiologics offer lucrative opportunities for market players. Companies are focusing on development of advanced and cost-effective orthobiologics in order to increase market share and presence.

Orthobiologics Market

Orthobiologics Market Introduction

Orthobiologics refer to a group of medical treatments that use biological materials, such as cells, tissues, and growth factors, to enhance the healing process of bone and soft tissue injuries. Regenerative medicines are typically used to improve the healing of musculoskeletal injuries, including fractures, ligament & tendon tears, and cartilage damage.

Platelet-rich plasma (PRP) therapy involves injecting a concentrated solution of a patient's own platelets, which are rich in growth factors, into an injured area to promote tissue regeneration and healing. Stem cell therapy involves using a patient's own stem cells or donor stem cells to regenerate damaged tissues. Bone grafting is the transplantation of bone tissue from one part of the body or a donor to a damaged area to stimulate bone growth and healing. Cartilage regeneration involves the usage of scaffolds or implants to promote the growth of new cartilage tissue in areas where it has been damaged or lost.

Orthobiologics are often used in conjunction with traditional orthopedic treatments, such as surgery and physical therapy, to help improve the healing process and reduce recovery time, regenerative medicines, and musculoskeletal injuries.

The surge in Sports Injuries Driving Global Orthobiologics Market Size

Sports injuries are common among athletes and individuals who engage in physical activities. These injuries range from mild strains and sprains to more severe injuries such as fractures and ligament tears. Orthobiologics, which include biological substances such as stem cells, growth factors, and platelet-rich plasma, has emerged as a promising treatment option for sports injuries.

The rise in the prevalence of sports injuries is one of the key drivers of the orthobiologics market. According to a report by the American Academy of Orthopaedic Surgeons (AAOS), sports injuries account for around 8.6 million visits to emergency departments in the U.S. each year. Common sports injuries include sprains and strains, which involve damage to the ligaments and muscles, and fractures. These injuries can be caused by a range of factors, including overuse, poor technique, and accidents.

Orthobiologics offer several advantages over traditional treatment options for sports injuries. For example, stem cells have the ability to differentiate into different types of cells and can promote tissue regeneration and repair. Platelet-rich plasma (PRP) contains growth factors that can stimulate the healing process and reduce inflammation. These biological substances can be injected directly into the site of injury, promoting faster healing and reducing the need for invasive surgery.

Several studies have demonstrated the effectiveness of orthobiologics in treating sports injuries. For example, a study published in the Journal of Orthopedic Research revealed that PRP injections improved the healing of Achilles tendon injuries in rats. Another study published in the American Journal of Sports Medicine indicated that the use of stem cells in the treatment of knee injuries resulted in improved function and pain relief.

According to the CDC, approximately 1.5 million sports and recreation-related traumatic brain injuries (TBIs) were treated in the U.S. emergency departments in 2018. The National Safety Council (NSC) reported that sports-related injuries are the second leading cause of emergency department visits for children and adolescents aged 5-19 years in the U.S. The most common types of sports injuries are sprains and strains, which account for about 40% of all sports injuries. Fractures make up about 10% of all sports injuries.

Rise in Prevalence Of Chronic Arthritis Propelling Global Orthobiologics Market Share

A collection of musculoskeletal conditions known as chronic arthritis involve joint inflammation and destruction, resulting in pain, stiffness, and decreased mobility. There are different types of arthritis; the two most prevalent are osteoarthritis and rheumatoid arthritis. All ages and genders can develop arthritis, although older persons and women are more likely to develop it than other groups.

According to the Centers for Disease Control and Prevention (CDC), an estimated 54.4 million adults in the U.S., or 22.7% of the population, have some form of arthritis. The prevalence of arthritis increases with age, with an estimated 49.6% of adults aged 65 years and older reporting arthritis. Arthritis is also more common in women than men, with an estimated 26.2% of women and 20.7% of men reporting arthritis.

According to the World Health Organization (WHO), an estimated 10% to 15% of the world's population is affected by arthritis. This equates to around 700 million to 1 billion people worldwide. The prevalence of arthritis varies by region and is influenced by factors such as age, genetics, lifestyle, and environmental factors.

Arthritis is a leading cause of disability globally, affecting individuals' ability to perform daily activities, work, and participate in social and recreational activities. The economic burden of arthritis is also significant, with direct medical costs and lost productivity estimated to be billions of dollars annually.

Rise in prevalence of chronic arthritis is driving the global orthobiologics market. Orthobiologics are biological substances that can be used to enhance the healing process of musculoskeletal injuries or disorders. These substances can be derived from natural sources such as bone, cartilage, or blood, or can be produced synthetically. Orthobiologics offer a less invasive option for treating chronic arthritis and other musculoskeletal disorders.

Surge in Demand for Viscosupplementation due to Better Lubrication and Cushioning

In terms of product, the global orthobiologics market has been classified into allografts, xenografts, synthetic bone grafts, demineralized bone matrix (DBM), viscosupplementation, platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC), and others. The viscosupplementation segment dominated the global market in 2022. Viscosupplementation refers to the injection of hyaluronic acid (HA) into the joint space to provide lubrication and cushioning for the affected joint.

Increase in Usage of Orthobiologics in Spinal Fusion Procedures

Based on application, the global orthobiologics market has been segregated into spinal fusion, trauma repair, reconstructive surgeries, fractures, osteoarthritis, maxillofacial and dental applications, and others. The spinal fusion segment accounted for major share of the global market in 2022. Usage of orthobiologics in spinal fusion procedures has become increasingly common in the past few years, as these have been shown to improve the outcome of these procedures and reduce the need for additional surgeries.

Regional Analysis

As per orthobiologics market trends, North America accounted for major share of the global market in 2022. The market in the region is likely to expand at a high CAGR from 2023 to 2031. This is ascribed to surge in prevalence of orthopedic disorders and injuries. According to the CDC, an estimated 54 million adults have been diagnosed with some form of arthritis in the U.S. alone, and this number is expected to rise to 78 million by 2040. Increase in incidence of orthopedic disorders is driving the demand for orthobiologic products, including bone graft substitutes, which are used in procedures, such as spinal fusion and joint reconstruction.

Asia Pacific is expected to be the fastest growing market for orthobiologics during the forecast period. This is ascribed to aging population, rise in prevalence of musculoskeletal disorders, and increase in demand for minimally invasive surgical procedures.

Analysis of Key Players in Global Orthobiologics Industry

The global market is fragmented, with the presence of large number of local as well as international players. Expansion of product portfolio and mergers & acquisitions are the key strategies adopted by the leading players. Alphatec Spine, Inc., Arthrex, Bioventus, Inc., Exactech, Inc., Global Medical, Inc., Integra Lifesciences, Medtronic, MTF Biologics, RTI Surgical, Sano Orthopedics, Sanofi, Seikagaku Corporation, Stryker, and Zimmer Biomet are the prominent players in the global orthobiologics market.

Key Developments in Global Orthobiologics Market

  • In July 2022, Bioventus, Inc. announced acquisition of CartiHeal. The purchase of CartiHeal strengthened the company's position as the industry leader in joint preservation technology and is connected with Bioventus' call points for sports medicine and complete joint repair. CartiHeal's Agili-C implant has proven to be superior to either microfracture or debridement in a randomized controlled clinical study.
  • In November 2021, Stryker announced that it acquired Gauss Surgical, a medical technology company that develops artificial intelligence-based software for surgical blood loss monitoring. The acquisition is expected to help Stryker enhance its offerings in orthopedic surgeries and spine surgeries, including its orthobiologics products.
  • In September 2021, Medtronic become the only firm offering an ecosystem for minimally invasive spine surgery by combining spinal implants, biologics, navigation, robots, and AI-powered data to surgeons and patients.

Each of these players has been profiled in the orthobiologics market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Global Orthobiologics Market Snapshot

Attribute

Detail

Size in 2022

US$ 8.4 Bn

Forecast (Value) in 2031

US$ 13.8 Bn

Growth Rate (CAGR)

5.5%

Forecast Period

2023–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Product
    • Allografts
    • Xenografts
    • Synthetic Bone Grafts
      • Hydroxyapatite
      • β-tricalcium phosphate (β-TCP)
      • BiPhasic
      • Bioactive glass
      • Others
    • Demineralized Bone Matrix (DBM)
    • Viscosupplementation
    • Platelet-rich Plasma (PRP)
    • Bone Marrow Aspirate Concentrate (BMAC)
    • Others
  • Application
    • Spinal Fusion
    • Trauma Repair
    • Reconstructive Surgeries
    • Fractures
    • Osteoarthritis
    • Maxillofacial & Dental Applications
    • Others
  • End-user
    • Hospitals
    • Orthopedic Clinics
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Japan
  • China
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Alphatec Spine, Inc.
  • Arthrex
  • Bioventus LLC
  • Exactech, Inc.
  • Global Medical, Inc.
  • Integra Lifesciences
  • Medtronic
  • MTF Biologics
  • RTI Surgical
  • Sano Orthopedics
  • Sanofi
  • Seikagaku Corporation
  • Stryker
  • Zimmer Biomet

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global orthobiologics market in 2022?

The global industry was valued at US$ 8.4 Bn in 2022

How big will the orthobiologics industry be in 2031?

It is projected to reach more than US$ 13.8 Bn by 2031

What will be the CAGR of the orthobiologics business during the forecast period?

The CAGR is anticipated to be 5.5% from 2023 to 2031.

What are the prominent trends that affect market growth?

Surge in sports injuries and rise in prevalence of chronic arthritis are driving the global market.

Which region is likely to account for major share during the forecast period?

North America is expected to account for the largest share of the global market during the forecast period.

Who are the prominent orthobiologics players?

Alphatec Spine, Inc., Arthrex, Bioventus LLC, Exactech, Inc., Global Medical, Inc., Integra Lifesciences, Medtronic, MTF Biologics, RTI Surgical, Sano Orthopedics, Sanofi, Seikagaku Corporation, Stryker, and Zimmer Biomet are the prominent players in the market.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Orthobiologics Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Segment Definition

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Orthobiologics Market Analysis and Forecast, 2017-2031

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Key Market Trends

        5.2. Merger & Acquisition

        5.3. Strategies of Top Five Players Operating in the Market

        5.4. Incidence of Orthopedic Disorder, by Key Countries

        5.5. Number of Surgical Procedures

        5.6. Regulatory and Reimbursement Scenario by Key Countries

        5.7. Covid-19 Pandemic Impact on the Industry

    6. Global Orthobiologics Market Analysis and Forecast, by Product

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Product, 2017-2031

            6.3.1. Allografts

            6.3.2. Xenografts

            6.3.3. Synthetic Bone Grafts

                6.3.3.1. Hydroxyapatite

                6.3.3.2. β-tricalcium Phosphate (β-TCP)

                6.3.3.3. BiPhasic

                6.3.3.4. Bioactive Glass

                6.3.3.5. Others

            6.3.4. Demineralized Bone Matrix (DBM)

            6.3.5. Viscosupplementation

            6.3.6. Platelet-rich Plasma (PRP)

            6.3.7. Bone Marrow Aspirate Concentrate (BMAC)

            6.3.8. Others

        6.4. Market Attractiveness Analysis, by Product

    7. Global Orthobiologics Market Analysis and Forecast, by Application

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by Application, 2017-2031

            7.3.1. Spinal Fusion

            7.3.2. Trauma Repair

            7.3.3. Reconstructive Surgeries

            7.3.4. Fractures

            7.3.5. Osteoarthritis

            7.3.6. Maxillofacial & Dental Applications

            7.3.7. Others

        7.4. Market Attractiveness Analysis, by Application

    8. Global Orthobiologics Market Analysis and Forecast, by End-user

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast, by End-user, 2017-2031

            8.3.1. Hospitals

            8.3.2. Orthopedic Clinics

            8.3.3. Others

        8.4. Market Attractiveness Analysis, by End-user

    9. Global Orthobiologics Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness Analysis, by Region

    10. North America Orthobiologics Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Product, 2017-2031

            10.2.1. Allografts

            10.2.2. Xenografts

            10.2.3. Synthetic Bone Grafts

                10.2.3.1. Hydroxyapatite

                10.2.3.2. β-tricalcium Phosphate (β-TCP)

                10.2.3.3. BiPhasic

                10.2.3.4. Bioactive Glass

                10.2.3.5. Others

            10.2.4. Demineralized Bone Matrix (DBM)

            10.2.5. Viscosupplementation

            10.2.6. Platelet-rich Plasma (PRP)

            10.2.7. Bone Marrow Aspirate Concentrate (BMAC)

            10.2.8. Others

        10.3. Market Value Forecast, by Application, 2017-2031

            10.3.1. Spinal Fusion

            10.3.2. Trauma Repair

            10.3.3. Reconstructive Surgeries

            10.3.4. Fractures

            10.3.5. Osteoarthritis

            10.3.6. Maxillofacial & Dental Applications

            10.3.7. Others

        10.4. Market Value Forecast, by End-user, 2017-2031

            10.4.1. Hospitals

            10.4.2. Orthopedic Clinics

            10.4.3. Others

        10.5. Market Value Forecast, by Country, 2017-2031

            10.5.1. U.S.

            10.5.2. Canada

        10.6. Market Attractiveness Analysis

            10.6.1. By Product

            10.6.2. By Application

            10.6.3. By End-user

            10.6.4. By Country

    11. Europe Orthobiologics Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product, 2017-2031

            11.2.1. Allografts

            11.2.2. Xenografts

            11.2.3. Synthetic Bone Grafts

                11.2.3.1. Hydroxyapatite

                11.2.3.2. β-tricalcium Phosphate (β-TCP)

                11.2.3.3. BiPhasic

                11.2.3.4. Bioactive Glass

                11.2.3.5. Others

            11.2.4. Demineralized Bone Matrix (DBM)

            11.2.5. Viscosupplementation

            11.2.6. Platelet-rich Plasma (PRP)

            11.2.7. Bone Marrow Aspirate Concentrate (BMAC)

            11.2.8. Others

        11.3. Market Value Forecast, by Application, 2017-2031

            11.3.1. Spinal Fusion

            11.3.2. Trauma Repair

            11.3.3. Reconstructive Surgeries

            11.3.4. Fractures

            11.3.5. Osteoarthritis

            11.3.6. Maxillofacial & Dental Applications

            11.3.7. Others

        11.4. Market Value Forecast, by End-user, 2017-2031

            11.4.1. Hospitals

            11.4.2. Orthopedic Clinics

            11.4.3. Others

        11.5. Market Value Forecast, by Country/Sub-region, 2017-2031

            11.5.1. Germany

            11.5.2. U.K.

            11.5.3. France

            11.5.4. Spain

            11.5.5. Italy

            11.5.6. Rest of Europe

        11.6. Market Attractiveness Analysis

            11.6.1. By Product

            11.6.2. By Application

            11.6.3. By End-user

            11.6.4. By Country/Sub-region

    12. Asia Pacific Orthobiologics Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product, 2017-2031

            12.2.1. Allografts

            12.2.2. Xenografts

            12.2.3. Synthetic Bone Grafts

                12.2.3.1. Hydroxyapatite

                12.2.3.2. β-tricalcium Phosphate (β-TCP)

                12.2.3.3. BiPhasic

                12.2.3.4. Bioactive Glass

                12.2.3.5. Others

            12.2.4. Demineralized Bone Matrix (DBM)

            12.2.5. Viscosupplementation

            12.2.6. Platelet-rich Plasma (PRP)

            12.2.7. Bone Marrow Aspirate Concentrate (BMAC)

            12.2.8. Others

        12.3. Market Value Forecast, by Application, 2017-2031

            12.3.1. Spinal Fusion

            12.3.2. Trauma Repair

            12.3.3. Reconstructive Surgeries

            12.3.4. Fractures

            12.3.5. Osteoarthritis

            12.3.6. Maxillofacial & Dental Applications

            12.3.7. Others

        12.4. Market Value Forecast, by End-user, 2017-2031

            12.4.1. Hospitals

            12.4.2. Orthopedic Clinics

            12.4.3. Others

        12.5. Market Value Forecast, by Country/Sub-region, 2017-2031

            12.5.1. China

            12.5.2. Japan

            12.5.3. India

            12.5.4. Australia & New Zealand

            12.5.5. Rest of Asia Pacific

        12.6. Market Attractiveness Analysis

            12.6.1. By Product

            12.6.2. By Application

            12.6.3. By End-user

            12.6.4. By Country/Sub-region

    13. Latin America Orthobiologics Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product, 2017-2031

            13.2.1. Allografts

            13.2.2. Xenografts

            13.2.3. Synthetic Bone Grafts

                13.2.3.1. Hydroxyapatite

                13.2.3.2. β-tricalcium Phosphate (β-TCP)

                13.2.3.3. BiPhasic

                13.2.3.4. Bioactive Glass

                13.2.3.5. Others

            13.2.4. Demineralized Bone Matrix (DBM)

            13.2.5. Viscosupplementation

            13.2.6. Platelet-rich Plasma (PRP)

            13.2.7. Bone Marrow Aspirate Concentrate (BMAC)

            13.2.8. Others

        13.3. Market Value Forecast, by Application, 2017-2031

            13.3.1. Spinal Fusion

            13.3.2. Trauma Repair

            13.3.3. Reconstructive Surgeries

            13.3.4. Fractures

            13.3.5. Osteoarthritis

            13.3.6. Maxillofacial & Dental Applications

            13.3.7. Others

        13.4. Market Value Forecast, by End-user, 2017-2031

            13.4.1. Hospitals

            13.4.2. Orthopedic Clinics

            13.4.3. Others

        13.5. Market Value Forecast, by Country, 2017-2031

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America

        13.6. Market Attractiveness Analysis

            13.6.1. By Product

            13.6.2. By Application

            13.6.3. By End-user

            13.6.4. By Country/Sub-region

    14. Middle East & Africa Orthobiologics Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Product, 2017-2031

            14.2.1. Allografts

            14.2.2. Xenografts

            14.2.3. Synthetic Bone Grafts

                14.2.3.1. Hydroxyapatite

                14.2.3.2. β-tricalcium Phosphate (β-TCP)

                14.2.3.3. BiPhasic

                14.2.3.4. Bioactive Glass

                14.2.3.5. Others

            14.2.4. Demineralized Bone Matrix (DBM)

            14.2.5. Viscosupplementation

            14.2.6. Platelet-rich Plasma (PRP)

            14.2.7. Bone Marrow Aspirate Concentrate (BMAC)

            14.2.8. Others

        14.3. Market Value Forecast, by Application, 2017-2031

            14.3.1. Spinal Fusion

            14.3.2. Trauma Repair

            14.3.3. Reconstructive Surgeries

            14.3.4. Fractures

            14.3.5. Osteoarthritis

            14.3.6. Maxillofacial & Dental Applications

            14.3.7. Others

        14.4. Market Value Forecast, by End-user, 2017-2031

            14.4.1. Hospitals

            14.4.2. Orthopedic Clinics

            14.4.3. Others

        14.5. Market Value Forecast, by Country/Sub-region, 2017-2031

            14.5.1. GCC Countries

            14.5.2. South Africa

            14.5.3. Rest of Middle East & Africa

        14.6. Market Attractiveness Analysis

            14.6.1. By Product

            14.6.2. By Application

            14.6.3. By End-user

            14.6.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player – Competition Matrix (by tier and size of companies)

        15.2. Market Share/Ranking Analysis, by Company, 2022

        15.3. Company Profiles

            15.3.1. Alphatec Spine, Inc.

                15.3.1.1. Company Overview

                15.3.1.2. Product Portfolio

                15.3.1.3. SWOT Analysis

                15.3.1.4. Strategic Overview

            15.3.2. Arthrex

                15.3.2.1. Company Overview

                15.3.2.2. Product Portfolio

                15.3.2.3. SWOT Analysis

                15.3.2.4. Strategic Overview

            15.3.3. Bioventus LLC

                15.3.3.1. Company Overview

                15.3.3.2. Product Portfolio

                15.3.3.3. SWOT Analysis

                15.3.3.4. Strategic Overview

            15.3.4. Exactech, Inc.

                15.3.4.1. Company Overview

                15.3.4.2. Product Portfolio

                15.3.4.3. SWOT Analysis

                15.3.4.4. Strategic Overview

            15.3.5. Global Medical, Inc.

                15.3.5.1. Company Overview

                15.3.5.2. Product Portfolio

                15.3.5.3. SWOT Analysis

                15.3.5.4. Strategic Overview

            15.3.6. Integra Lifesciences

                15.3.6.1. Company Overview

                15.3.6.2. Product Portfolio

                15.3.6.3. SWOT Analysis

                15.3.6.4. Strategic Overview

            15.3.7. Medtronic

                15.3.7.1. Company Overview

                15.3.7.2. Product Portfolio

                15.3.7.3. SWOT Analysis

                15.3.7.4. Strategic Overview

            15.3.8. MTF Biologics

                15.3.8.1. Company Overview

                15.3.8.2. Product Portfolio

                15.3.8.3. SWOT Analysis

                15.3.8.4. Strategic Overview

            15.3.9. RTI Surgical

                15.3.9.1. Company Overview

                15.3.9.2. Product Portfolio

                15.3.9.3. SWOT Analysis

                15.3.9.4. Strategic Overview

            15.3.10. Sano Orthopedics

                15.3.10.1. Company Overview

                15.3.10.2. Product Portfolio

                15.3.10.3. SWOT Analysis

                15.3.10.4. Strategic Overview

            15.3.11. Sanofi

                15.3.11.1. Company Overview

                15.3.11.2. Product Portfolio

                15.3.11.3. SWOT Analysis

                15.3.11.4. Strategic Overview

            15.3.12. Seikagaku Corporation

                15.3.12.1. Company Overview

                15.3.12.2. Product Portfolio

                15.3.12.3. SWOT Analysis

                15.3.12.4. Strategic Overview

            15.3.13. Stryker

                15.3.13.1. Company Overview

                15.3.13.2. Product Portfolio

                15.3.13.3. SWOT Analysis

                15.3.13.4. Strategic Overview

            15.3.14. Zimmer Biomet

                15.3.14.1. Company Overview

                15.3.14.2. Product Portfolio

                15.3.14.3. SWOT Analysis

                15.3.14.4. Strategic Overview

    List of Tables

    Table 01: Global Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017‒2031

    Table 02: Global Orthobiologics Market Value (US$ Mn) Forecast, by 2017‒2031, by Application

    Table 03: Global Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 04: Global Orthobiologics Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 05: North America Orthobiologics Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 06: North America Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017‒2031

    Table 07: North America Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017‒2031

    Table 08: North America Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 09: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 10: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017‒2031

    Table 11: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017‒2031

    Table 12: Europe Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 13: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 14: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017‒2031

    Table 15: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017‒2031

    Table 16: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 17: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 18: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017‒2031

    Table 19: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017‒2031

    Table 20: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 21: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 22: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017‒2031

    Table 23: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017‒2031

    Table 24: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    List of Figures

    Figure 01: Global Orthobiologics Market Value (US$ Mn) Forecast, 2017–2031

    Figure 02: Global Orthobiologics Market Value Share, by Product, 2021

    Figure 03: Global Orthobiologics Market Value Share, by Application, 2021

    Figure 04: Global Orthobiologics Market Value Share, by End-user, 2021

    Figure 05: Global Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031

    Figure 06: Global Orthobiologics Market Attractiveness Analysis, by Product, 2023–2031

    Figure 07: Global Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031

    Figure 08: Global Orthobiologics Market Attractiveness Analysis, by Application, 2023–2031

    Figure 09: Global Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 10: Global Orthobiologics Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 11: Global Orthobiologics Market Value Share Analysis, by Region, 2021 and 2031

    Figure 12: Global Orthobiologics Market Attractiveness Analysis, by Region, 2023–2031

    Figure 13: North America Orthobiologics Market Value (US$ Mn) Forecast, 2017–2031

    Figure 14: North America Orthobiologics Market Value Share Analysis, by Country, 2021 and 2031

    Figure 15: North America Orthobiologics Market Attractiveness Analysis, by Country, 2023–2031 

    Figure 16: North America Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031

    Figure 17: North America Orthobiologics Market Attractiveness Analysis, by Product, 2023–2031

    Figure 18: North America Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031

    Figure 19: North America Orthobiologics Market Attractiveness Analysis, by Application, 2023–2031

    Figure 20: North America Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 21: North America Orthobiologics Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 22: Europe Orthobiologics Market Value (US$ Mn) Forecast, 2017–2031

    Figure 23: Europe Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 24: Europe Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 25: Europe Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031

    Figure 26: Europe Orthobiologics Market Attractiveness Analysis, by Product, 2023–2031

    Figure 27: Europe Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031

    Figure 28: Europe Orthobiologics Market Attractiveness Analysis, by Application, 2023–2031

    Figure 29: Europe Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 30: Europe Orthobiologics Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 31: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, 2017–2031

    Figure 32: Asia Pacific Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 33: Asia Pacific Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 34: Asia Pacific Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031

    Figure 35: Asia Pacific Orthobiologics Market Attractiveness Analysis, by Product, 2023–2031

    Figure 36: Asia Pacific Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031

    Figure 37: Asia Pacific Orthobiologics Market Attractiveness Analysis, by Application, 2023–2031

    Figure 38: Asia Pacific Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 39: Asia Pacific Orthobiologics Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 40: Latin America Orthobiologics Market Value (US$ Mn) Forecast, 2017–2031

    Figure 41: Latin America Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 42: Latin America Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2021-2031

    Figure 43: Latin America Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031

    Figure 44: Latin America Orthobiologics Market Attractiveness Analysis, by Product, 2023–2031

    Figure 45: Latin America Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031

    Figure 46: Latin America Orthobiologics Market Attractiveness Analysis, by Application, 2023–2031

    Figure 47: Latin America Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 48: Latin America Orthobiologics Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 49: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, 2017–2031

    Figure 50: Middle East & Africa Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 51: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2021-2031

    Figure 52: Middle East & Africa Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031

    Figure 53: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Product, 2023–2031

    Figure 54: Middle East & Africa Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031

    Figure 55: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Application, 2023–2031

    Figure 56: Middle East & Africa Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 57: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 58: Company Share Analysis, 2021

Copyright © Transparency Market Research, Inc. All Rights reserved